GAMMA Investing LLC Purchases 62,267 Shares of Core Laboratories Inc. (NYSE:CLB)

GAMMA Investing LLC increased its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 972.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 68,669 shares of the oil and gas company's stock after purchasing an additional 62,267 shares during the period. GAMMA Investing LLC owned about 0.15% of Core Laboratories worth $1,029,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Assetmark Inc. acquired a new position in shares of Core Laboratories in the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC grew its position in Core Laboratories by 173.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock valued at $35,000 after purchasing an additional 1,293 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in Core Laboratories by 843.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company's stock valued at $57,000 after buying an additional 2,936 shares during the period. BNP Paribas Financial Markets purchased a new stake in Core Laboratories in the 4th quarter worth approximately $123,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in shares of Core Laboratories during the 4th quarter valued at $149,000. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CLB has been the topic of several research analyst reports. Wall Street Zen cut shares of Core Laboratories from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Citigroup lowered their target price on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 13th. Finally, Stifel Nicolaus dropped their target price on Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a research report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $15.00.

Core Laboratories Stock Down 1.0%

CLB stock traded down $0.12 during trading hours on Friday, hitting $12.46. The company's stock had a trading volume of 344,194 shares, compared to its average volume of 403,924. The stock has a 50 day moving average price of $11.75 and a two-hundred day moving average price of $15.03. Core Laboratories Inc. has a 12 month low of $10.14 and a 12 month high of $25.13. The company has a market capitalization of $584.12 million, a PE ratio of 21.12, a price-to-earnings-growth ratio of 3.87 and a beta of 1.40. The company has a quick ratio of 1.64, a current ratio of 2.21 and a debt-to-equity ratio of 0.48.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Core Laboratories had a return on equity of 15.06% and a net margin of 5.41%. The business had revenue of $123.59 million during the quarter, compared to the consensus estimate of $125.09 million. During the same quarter in the prior year, the company posted $0.19 earnings per share. The company's revenue for the quarter was down 4.7% on a year-over-year basis. On average, equities research analysts expect that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Monday, May 5th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend was Monday, May 5th. Core Laboratories's payout ratio is 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.